Manipal Hospitals, which acquired an 84 per cent stake in AMRI Hospitals in September 2023 for around Rs 2,300 crore, announced brand integration on Tuesday
Pai recently invested $168 million (Rs 1,400 crore) in edtech firm Byju's test-prep subsidiary AESL and was in discussion to invest about $350 million in Byju's in both equity and debt
Besides Pai's commitment, PharmEasy raised the remaining Rs 2,200 crore from existing shareholders
Given the past and the present, it was not a surprise that early this year Raveendran reached out to Pai and the outcome has been prompt
Industry sources said that Pai of Manipal Group paid out Davidson Kempner in a bilateral debt transaction
Manipal Education and Medical Group Chairman Ranjan Pai has also secured a seat on Byju's subsidiary, Aakash
With this transaction, JSW Ventures has fully exited its stake in Purplle from Fund I and has returned 2.7 times the fund size to its investors so far
The capital from Pai is expected to help Byju's release the pledge on shares of Aakash, which were offered as collateral for the Davidson Kempner loan
Company buys remaining stake in peer after first deal in 2022 gave it 84%
Will Manipal be Byju's white knight? Can below-normal August rains affect food inflation? How should you trade in a range-bound market? How is low-cost airline different from a full-service airline?
Raveendran may partially offload his stake for $80-90 mn
The fundraising will be done via a rights issue where the stock will be sold at a 90 per cent discount at Rs 5 per share
The Competition Commission of India (CCI) on Tuesday said it has cleared the proposed deal involving Manipal Health Enterprises Pvt Ltd and Manipal Education and Medical Group India Pvt Ltd (MEMG India). Manipal Health Enterprises Pvt Ltd (MHEPL) operates a chain of multi-speciality hospitals under the brand name 'Manipal Hospitals', while MEMG India is a wholly-owned subsidiary of RSP Trust India and belongs to the Pai family group. In a tweet on Tuesday, CCI said it has approved the "proposed combination involving Manipal Health Enterprises Private Limited and Manipal Education and Medical Group India Private Limited". The deals beyond a certain threshold require approval from the regulator, which keeps a tab on unfair business practices as well as promotes fair competition in the marketplace.
Bengaluru-based hospital chain is focusing on adding beds - both organically and inorganically - and offering more high-end and complex surgeries for growth and profit
In a Q&A, Dr Ranjan Pai also confirms that Manipal Health will look for a listing going forward
Pai is charting an ambitious course for his group in his characteristic self-assured and understated manner, writes Anjuli Bhargava
S Vaitheeswaran talks about the possible ways to bridge the gap in skilled manpower in the sector
Our focus right now is to complete the transaction and the integration, said Pai
The deal may mark the exit of US based hospital chain from India
Plans organic expansion after unsuccessful attempts to acquire Fortis, Medanta hospitals